An Entirely Subcutaneous Implantable Cardioverter-DefibrillatorBARDY, Gust H; SMITH, Warren M; FYNN, Simon P et al.The New England journal of medicine. 2010, Vol 363, Num 1, pp 36-44, issn 0028-4793, 9 p.Article

Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) RegistrySCHWARTZ, Peter J; SPAZZOLINI, Carla; TOIVONEN, Lauri et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 13, pp 1272-1282, issn 0009-7322, 11 p.Article

Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyOLDE NORDKAMP, Louise R. A; KNOPS, Reinoud E; HERRMAN, Jean Paul R et al.The American heart journal. 2012, Vol 163, Num 5, pp 753-760, issn 0002-8703, 8 p.Article

The Entirely Subcutaneous Implantable Cardioverter-Defibrillator: Initial Clinical Experience in a Large Dutch CohortOLDE NORDKAMP, Louise R. A; DABIRI ABKENARI, Lara; BOERSMA, Lucas V. A et al.Journal of the American College of Cardiology. 2012, Vol 60, Num 19, pp 1933-1939, issn 0735-1097, 7 p.Article

Permanent Leadless Cardiac Pacing: Results of the LEADLESS TrialREDDY, Vivek Y; KNOPS, Reinoud E; OSTROSFF, Alan et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 14, pp 1466-1471, issn 0009-7322, 6 p.Article